Investors

Press Releases

Date Title View
Toggle Summary Momenta Pharmaceuticals Announces Exercise of Over-Allotment Option
Momenta Pharmaceuticals Announces Exercise of Over-Allotment Option CAMBRIDGE, MA - June 28, 2004 – Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) announced today that the underwriters of the Company's recent initial public offering of 5,350,000 shares of common stock exercised in full their
View HTML
Toggle Summary Momenta Pharmaceuticals Announces Pricing of Initial Public Offering
Momenta Pharmaceuticals Announces Pricing of Initial Public Offering CAMBRIDGE, Mass., June 21 /PRNewswire-FirstCall/ -- Momenta Pharmaceuticals, Inc. announced today the pricing of its initial public offering of 5,350,000 shares of common stock at a price of $6.50 per share.
View HTML